AAAAAA
Results: 1-25/28
Authors:
Yousfi, D
Azizi, M
Saad, A
Citation: D. Yousfi et al., A new position and speed estimation technique for PMSM with drift correction of the flux linkage, EL POW CO S, 29(7), 2001, pp. 597-613
Authors:
La Batide-Alanore, A
Azizi, M
Froissart, M
Raynaud, A
Plouin, PF
Citation: A. La Batide-alanore et al., Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis, J AM S NEPH, 12(6), 2001, pp. 1235-1241
Authors:
Vuagnat, A
Giacche, M
Hopkins, PN
Azizi, M
Hunt, SC
Vedie, B
Corvol, P
Williams, GH
Jeunemaitre, X
Citation: A. Vuagnat et al., Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs, J MOL MED-J, 79(4), 2001, pp. 175-183
Authors:
Boutouyrie, P
Corvisier, R
Azizi, M
Lemoine, D
Laloux, B
Hallouin, MC
Laurent, S
Citation: P. Boutouyrie et al., Effects of acupuncture on radial artery hemodynamics: controlled trials insensitized and naive subjects, AM J P-HEAR, 280(2), 2001, pp. H628-H633
Authors:
Mahboudi, F
Abolhassani, M
Yaran, M
Mobtaker, H
Azizi, M
Citation: F. Mahboudi et al., Identification and differentiation of Iranian Leishmania species by PCR amplification of kDNA, SC J IN DIS, 33(8), 2001, pp. 596-598
Authors:
Junot, C
Gonzales, MF
Ezan, E
Cotton, J
Vazeux, G
Michaud, A
Azizi, M
Vassiliou, S
Yiotakis, A
Corvol, P
Dive, V
Citation: C. Junot et al., RXP 407, a selective inhibitor of the N-domain of angiotensin I-convertingenzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis, J PHARM EXP, 297(2), 2001, pp. 606-611
Authors:
Boutouyrie, P
Corvisier, R
Serreau, R
Azizi, M
Lemoine, D
Laloux, B
Hallouin, MC
Laurent, S
Citation: P. Boutouyrie et al., Effects of acupuncture on radial arterial flow: Two controlled trials in pre-exposed and in naive healthy subjects, ARCH MAL C, 94(8), 2001, pp. 913-917
Authors:
Zouggar, S
Charif, HN
Azizi, M
Citation: S. Zouggar et al., Neural control and transient analysis of the LCL-type resonant converter, EPJ-APPL PH, 11(1), 2000, pp. 21-27
Authors:
Unger, T
Azizi, M
Belz, GG
Citation: T. Unger et al., Blocking the tissue renin-angiotensin system: the future cornerstone of therapy, J HUM HYPER, 14, 2000, pp. S23-S31
Authors:
Gordh, T
Sharma, HS
Azizi, M
Alm, P
Westman, J
Citation: T. Gordh et al., Spinal nerve lesion induces upregulation of constitutive isoform of heme oxygenase in the spinal cord - An immunohistochemical investigation in the rat, AMINO ACIDS, 19(1), 2000, pp. 373-381
Authors:
Azizi, M
Linhart, A
Alexander, J
Goldberg, A
Menten, J
Sweet, C
Menard, J
Citation: M. Azizi et al., Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients, J HYPERTENS, 18(8), 2000, pp. 1139-1147
Authors:
Azizi, M
Massien, C
Michaud, A
Corvol, P
Citation: M. Azizi et al., In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor, HYPERTENSIO, 35(6), 2000, pp. 1226-1231
Authors:
Laurent, S
Boutouyrie, P
Azizi, M
Marie, C
Gros, C
Schwartz, JC
Lecomte, JM
Bralet, J
Citation: S. Laurent et al., Antihypertensive effects of fasidotril, a dual inhibitor of neprilysin andangiotensin-converting enzyme, in rats and humans, HYPERTENSIO, 35(5), 2000, pp. 1148-1153
Authors:
Giacche, M
Vuagnat, A
Hunt, SC
Hopkins, PN
Fisher, NDL
Azizi, M
Corvol, P
Williams, GH
Jeunemaitre, X
Citation: M. Giacche et al., Aldosterone stimulation by angiotensin II - influence of gender, plasma renin, and familial resemblance, HYPERTENSIO, 35(3), 2000, pp. 710-716
Authors:
Legrain, S
Massien, C
Lahlou, N
Roger, M
Debuire, B
Diquet, B
Chatellier, G
Azizi, M
Faucounau, V
Porchet, H
Forette, F
Baulieu, EE
Citation: S. Legrain et al., Dehydroepiandrosterone replacement administration: Pharmacokinetic and pharmacodynamic studies in healthy elderly subjects, J CLIN END, 85(9), 2000, pp. 3208-3217
Authors:
Azizi, M
Hallouin, MC
Jeunemaitre, X
Guyene, TT
Menard, J
Citation: M. Azizi et al., Influence of the M235T polymorphism of human angiotensinogen (AGT) on plasma AGT and renin concentrations after ethinylestradiol administration, J CLIN END, 85(11), 2000, pp. 4331-4337
Authors:
Cherrak, I
Jaulent, MC
Azizi, M
Plouin, PF
Degoulet, P
Chatellier, G
Citation: I. Cherrak et al., Can the degree of renal artery stenosis be quantified automatically?, ARCH MAL C, 93(8), 2000, pp. 1047-1052
Authors:
Azizi, M
Shrout, MK
Haas, AJ
Russell, CM
Hamilton, EH
Citation: M. Azizi et al., A retrospective study of Angle Class I malocclusions treated orthodontically without extractions using two palatal expansion methods, AM J ORTHOD, 116(1), 1999, pp. 101-107
Authors:
Azizi, M
Chatellier, G
Guyene, TT
Menard, J
Citation: M. Azizi et al., Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan, J HYPERTENS, 17(4), 1999, pp. 561-568
Authors:
Azizi, M
Ezan, E
Reny, JL
Wdzieczak-Bakala, J
Gerineau, V
Menard, J
Citation: M. Azizi et al., Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans, HYPERTENSIO, 33(3), 1999, pp. 879-886
Authors:
Azizi, M
Citation: M. Azizi, Bradykinin and inhibition of angiotensin-converting enzyme in hypertension, N ENG J MED, 340(12), 1999, pp. 967-967
Authors:
Hojat, M
Shapurian, R
Nayerahmadi, H
Farzaneh, M
Foroughi, D
Parsi, M
Azizi, M
Citation: M. Hojat et al., Premarital sexual, child rearing, and family attitudes of Iranian men and women in the United States and in Iran, J PSYCHOL, 133(1), 1999, pp. 19-31
Authors:
Junot, C
Nicolet, L
Ezan, E
Gonzales, MF
Menard, J
Azizi, M
Citation: C. Junot et al., Effect of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats, J PHARM EXP, 291(3), 1999, pp. 982-987
Authors:
Volland, H
Pradelles, P
Ronco, P
Azizi, M
Simon, D
Creminon, C
Grassi, J
Citation: H. Volland et al., A solid-phase immobilized epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma, J IMMUNOL M, 228(1-2), 1999, pp. 37-47
Authors:
Massien, C
Azizi, M
Guyene, TT
Vesterqvist, O
Mangold, B
Menard, J
Citation: C. Massien et al., Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans, CLIN PHARM, 65(4), 1999, pp. 448-459